SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-010292
Filing Date
2023-06-23
Accepted
2023-06-23 20:00:35
Documents
1
Period of Report
2023-06-22

Document Format Files

Seq Description Document Type Size
1 form4-06232023_080626.html 4  
1 form4-06232023_080626.xml 4 10683
  Complete submission text file 0001415889-23-010292.txt   12035
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
Kala Pharmaceuticals, Inc. (Issuer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KALA PHARMACEUTICALS, INC. 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address
Farid Marjan (Reporting) CIK: 0001952098 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38150 | Film No.: 231039215